Loading
Latest filing published 10 Feb 2025 for Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.), €10k.
This profile gathers the share dealings of Brendon Buschman in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). In total, 3 filings cover trades dated from 26 June 2024 to 10 February 2025.
On the market, this insider has only ever bought: 2 purchases, €34k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2025 to date brings 2 purchases and no sales.
The newest entry dates from 10 February 2025: an open-market purchase of €10k, in Medexus Pharmaceuticals Inc. (formerly Pediapharm Inc.). Typically, a trade is published a median of 2 days after it takes place. Until a filing is published, the market cannot know about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations